Literature DB >> 8302280

Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.

C L Chio1, M E Lajiness, R M Huff.   

Abstract

Recombinant rat D3 dopamine receptors heterologously expressed in Chinese hamster ovary (CHO) cells are functionally coupled to endogenous G proteins. The affinity of the receptors for agonists is regulated by guanine nucleotides in the same manner as that of other G protein-linked receptors. The magnitude of the change in affinity induced by GTP is much less, however, than what is observed for recombinant rat D2 receptors expressed in CHO cells at similar densities. The striking difference is that the low affinity state (uncoupled D3 receptors) has a much higher affinity for agonists than does the low affinity state (uncoupled) of D2 receptors. Both receptors in the high affinity state (G protein coupled) have similar affinities for dopamine. Three functional responses result from activation of D3 or D2 receptors expressed in CHO cells. Both receptor subtypes mediate inhibition of adenylyl cyclase activity, increases in extracellular acidification rates that are prevented by removal of external Na+ and by amiloride analogs, and stimulation of cell division. However, these three functional results of D3 and D2 receptor activation are both quantitatively and qualitatively different. Dopamine activation of D3 receptors is always 2-5-fold less efficacious than dopamine activation of D2 receptors, despite similar densities of receptors. Both D3 and D2 receptor-mediated increases in extracellular acidification rates are blocked by pertussis toxin; however, the D3 response and not the D2 response is partially attenuated by membrane-soluble cAMP analogs. D3 and D2 receptor-mediated stimulation of mitogenesis is blocked by pertussis toxin and unaffected by cAMP analogs. The results show that D2 and D3 dopamine receptors mediate similar signaling events and are additional examples of G protein-linked receptors that can activate more than one pathway. Having functionally coupled D2 and D3 receptors expressed in the same cell type enabled determinations of agonist potencies at both D2 and D3 receptors. Comparison of the potencies at the two receptors reveals that none of the agonists is as selective for D3 receptors as was previously thought based on radioligand binding data.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302280

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  37 in total

1.  Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders.

Authors:  Pierre Sokoloff; Olivier Guillin; Jorge Diaz; Patrick Carroll; Nathalie Griffon
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

2.  Coupling of dopamine receptors to G proteins: studies with chimeric D2/D3 dopamine receptors.

Authors:  Tal Ilani; C Simone Fishburn; Berta Levavi-Sivan; Shari Carmon; Lily Raveh; Sara Fuchs
Journal:  Cell Mol Neurobiol       Date:  2002-02       Impact factor: 5.046

Review 3.  Dopamine Receptors and Neurodegeneration.

Authors:  Claudia Rangel-Barajas; Israel Coronel; Benjamín Florán
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

4.  Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse model.

Authors:  Ying Li; Eldo V Kuzhikandathil
Journal:  Brain Struct Funct       Date:  2012-01-29       Impact factor: 3.270

5.  Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.

Authors:  Mark J Millan; Loretta Iob; Jean-Louis Péglion; Anne Dekeyne
Journal:  Psychopharmacology (Berl)       Date:  2006-09-19       Impact factor: 4.530

Review 6.  Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.

Authors:  Amy E Moritz; R Benjamin Free; David R Sibley
Journal:  Cell Signal       Date:  2017-07-14       Impact factor: 4.315

Review 7.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

8.  A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons.

Authors:  D Lévesque; M P Martres; J Diaz; N Griffon; C H Lammers; P Sokoloff; J C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Dopamine transporter blockade increases LTP in the CA1 region of the rat hippocampus via activation of the D3 dopamine receptor.

Authors:  Jarod Swant; John J Wagner
Journal:  Learn Mem       Date:  2006 Mar-Apr       Impact factor: 2.460

10.  Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities.

Authors:  J K Staley; D C Mash
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.